These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32457351)

  • 1. CCL3-CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways.
    Kodama T; Koma YI; Arai N; Kido A; Urakawa N; Nishio M; Shigeoka M; Yokozaki H
    Lab Invest; 2020 Sep; 100(9):1140-1157. PubMed ID: 32457351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma.
    Shigeoka M; Urakawa N; Nishio M; Takase N; Utsunomiya S; Akiyama H; Kakeji Y; Komori T; Koma Y; Yokozaki H
    Cancer Med; 2015 Mar; 4(3):437-46. PubMed ID: 25620088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways.
    Urakawa N; Utsunomiya S; Nishio M; Shigeoka M; Takase N; Arai N; Kakeji Y; Koma Y; Yokozaki H
    Lab Invest; 2015 May; 95(5):491-503. PubMed ID: 25730371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL3-CCR5 axis promotes cell migration and invasion of colon adenocarcinoma via Akt signaling pathway.
    Guan B; Li H; Yao J; Guo J; Yu F; Li G; Wan B; Ma J; Huang D; Sun L; Chen Y
    Environ Toxicol; 2023 Jan; 38(1):172-184. PubMed ID: 36346222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine (C-C Motif) Ligand 1 Derived from Tumor-Associated Macrophages Contributes to Esophageal Squamous Cell Carcinoma Progression via CCR8-Mediated Akt/Proline-Rich Akt Substrate of 40 kDa/Mammalian Target of Rapamycin Pathway.
    Fujikawa M; Koma YI; Hosono M; Urakawa N; Tanigawa K; Shimizu M; Kodama T; Sakamoto H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Am J Pathol; 2021 Apr; 191(4):686-703. PubMed ID: 33460563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL8 derived from tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression by promoting migration and invasion of cancer cells.
    Hosono M; Koma YI; Takase N; Urakawa N; Higashino N; Suemune K; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Oncotarget; 2017 Dec; 8(62):106071-106088. PubMed ID: 29285315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells.
    Takase N; Koma Y; Urakawa N; Nishio M; Arai N; Akiyama H; Shigeoka M; Kakeji Y; Yokozaki H
    Cancer Lett; 2016 Sep; 380(1):47-58. PubMed ID: 27317650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.
    Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A
    Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocyte elevated gene-1 regulates CCL3/CCR5-induced epithelial-to-mesenchymal transition via Erk1/2 and Akt signaling in cardiac myxoma.
    Shi P; Fang C; Pang X
    Oncol Rep; 2015 Sep; 34(3):1319-26. PubMed ID: 26134542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANXA10 induction by interaction with tumor-associated macrophages promotes the growth of esophageal squamous cell carcinoma.
    Kodaira H; Koma YI; Hosono M; Higashino N; Suemune K; Nishio M; Shigeoka M; Yokozaki H
    Pathol Int; 2019 Mar; 69(3):135-147. PubMed ID: 30758105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell-like Phenotype via Dysregulation of PITX2.
    Zhang JX; Chen ZH; Xu Y; Chen JW; Weng HW; Yun M; Zheng ZS; Chen C; Wu BL; Li EM; Fu JH; Ye S; Xie D
    Clin Cancer Res; 2017 Jan; 23(1):298-310. PubMed ID: 27407092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-derived exosomal hyaluronidase 1 induced M2 macrophage polarization and promoted esophageal cancer progression.
    Yuan J; Hou B; Guo K; Zhu J; Xiao H
    Exp Cell Res; 2024 Jun; 439(1):113963. PubMed ID: 38382806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
    Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
    BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism.
    Zhang HF; Alshareef A; Wu C; Li S; Jiao JW; Cao HH; Lai R; Xu LY; Li EM
    Oncotarget; 2015 Oct; 6(30):28949-60. PubMed ID: 26334393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated CC receptor/ligand in monocytes/macrophages from tongue squamous cell carcinoma patients is partially rectified by interferon α-2b.
    Chakraborty K; Bose A; Goswami KK; Mukherjee KK; Goswami S; Ghosh D; Chakraborty T; Sarkar K; Pal S; Bhowmick A; Biswas J; Baral R
    Hum Immunol; 2012 Jan; 73(1):38-47. PubMed ID: 22085486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periostin in Cancer-Associated Fibroblasts Promotes Esophageal Squamous Cell Carcinoma Progression by Enhancing Cancer and Stromal Cell Migration.
    Miyako S; Koma YI; Nakanishi T; Tsukamoto S; Yamanaka K; Ishihara N; Azumi Y; Urakami S; Shimizu M; Kodama T; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Am J Pathol; 2024 May; 194(5):828-848. PubMed ID: 38320632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal adhesion kinase (FAK) inhibitor-defactinib suppresses the malignant progression of human esophageal squamous cell carcinoma (ESCC) cells via effective blockade of PI3K/AKT axis and downstream molecular network.
    Zhang L; Zhao D; Wang Y; Zhang W; Zhang J; Fan J; Zhan Q; Chen J
    Mol Carcinog; 2021 Feb; 60(2):113-124. PubMed ID: 33283357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma.
    Shigeoka M; Urakawa N; Nakamura T; Nishio M; Watajima T; Kuroda D; Komori T; Kakeji Y; Semba S; Yokozaki H
    Cancer Sci; 2013 Aug; 104(8):1112-9. PubMed ID: 23648122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant Chemotherapy Induces IL34 Signaling and Promotes Chemoresistance via Tumor-Associated Macrophage Polarization in Esophageal Squamous Cell Carcinoma.
    Nakajima S; Mimura K; Saito K; Thar Min AK; Endo E; Yamada L; Kase K; Yamauchi N; Matsumoto T; Nakano H; Kanke Y; Okayama H; Saito M; Neupane P; Saze Z; Watanabe Y; Hanayama H; Hayase S; Kaneta A; Momma T; Ohki S; Ohira H; Kono K
    Mol Cancer Res; 2021 Jun; 19(6):1085-1095. PubMed ID: 33674443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.